We are a Swedish biotech company developing Sepranolone for Allopregnanolone-related stress, menstrual and neurological disorders. Our product pipeline is built on over 40 years’ research. We believe that our new family of GAMSA compounds (GABAA Modulating Steroid Antagonists) represents a new generation of effective, safe drugs for conditions ranging from Tourette to Menstrual Migraine – and more. It’s great to welcome you to the company – please don’t hesitate to contact us and find out more about our offer, products or pipeline!
The Company’s Certified Adviser is
Carnegie Investment Bank AB (publ)
Telefon: +46 (0)73 856 42 65